.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Covington
Cantor Fitzgerald
Baxter
Chinese Patent Office
Cipla
Chubb
Argus Health
Federal Trade Commission
AstraZeneca

Generated: November 21, 2017

DrugPatentWatch Database Preview

Inamrinone lactate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for inamrinone lactate and what is the scope of inamrinone lactate patent protection?

Inamrinone lactate
is the generic ingredient in two branded drugs marketed by Sanofi Aventis Us, West-ward Pharms Int, Hospira, and Baxter Hlthcare Corp, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for inamrinone lactate.

Summary for inamrinone lactate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us
INOCOR
inamrinone lactate
INJECTABLE;INJECTION018700-001Jul 31, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMRINONE LACTATE
inamrinone lactate
INJECTABLE;INJECTION074616-001Aug 3, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Baxter Hlthcare Corp
AMRINONE LACTATE
inamrinone lactate
INJECTABLE;INJECTION075542-001May 10, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
AMRINONE LACTATE
inamrinone lactate
INJECTABLE;INJECTION075513-001May 9, 2000RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: inamrinone lactate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us
INOCOR
inamrinone lactate
INJECTABLE;INJECTION018700-001Jul 31, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Baxter
QuintilesIMS
Cantor Fitzgerald
Healthtrust
Chinese Patent Office
Fuji
Dow
Covington
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot